Subsequent to the PTX100 webinar, SYC also referenced an update...

Subsequent to the PTX100 webinar, SYC also referenced an update on the PTX100 efficacy data in the Investor Briefing. At 11:30 he states, "We are about to put out another update... some short term news. I won't say any more on that." and at 12:24 he says, "Stayed tuned on that [case] study" .... referring to the patient who has left the trial deemed a complete response!

https://prescienttherapeutics.investorportal.com.au/

So, yeah, I think we are right in expecting an update this week. Dare say that the data is being collated and an announcement on its way any day now.